CC([O-])=O.[Na+].[CH3:6][O:7][C:8]([C:10]1[CH:11]=[CH:12][C:13]2[C:18](=O)[CH2:17][S:16](=[O:21])(=[O:20])[N:15]([CH3:22])[C:14]=2[CH:23]=1)=[O:9].Cl.[NH2:25][OH:26]>CCO>[CH3:6][O:7][C:8]([C:10]1[CH:11]=[CH:12][C:13]2[C:18](=[N:25][OH:26])[CH2:17][S:16](=[O:21])(=[O:20])[N:15]([CH3:22])[C:14]=2[CH:23]=1)=[O:9]NaOAc (3.66 g, 44.5 mmol) was added to an EtOH (100 mL) solution of 1-methyl-2,2,4-trioxo-1,2,3,4-tetrahydro-2λ6-benzo[c][1,2]thiazine-7-carboxylic acid methyl ester (4.00 g, 14.8 mmol) and hydroxylamine hydrochloride (1.55 g, 22.3 mmol). After heating at reflux for 4 days, it was evaporated, diluted with CH2Cl2 (400 mL), washed with H2O, dried over MgSO4, filtered, and concentrated in vacuo. Crystallization from MeOH provided the title compound. MS (−APCI, m/z): 283 (M−H)−.